[go: up one dir, main page]

MX9207394A - Esteroides de 17-espirofuran-3'-ilideno. - Google Patents

Esteroides de 17-espirofuran-3'-ilideno.

Info

Publication number
MX9207394A
MX9207394A MX9207394A MX9207394A MX9207394A MX 9207394 A MX9207394 A MX 9207394A MX 9207394 A MX9207394 A MX 9207394A MX 9207394 A MX9207394 A MX 9207394A MX 9207394 A MX9207394 A MX 9207394A
Authority
MX
Mexico
Prior art keywords
steroids
ilideno
espirofuran
spirofuran
medicament
Prior art date
Application number
MX9207394A
Other languages
English (en)
Inventor
Johannes Antonius
Maria Hamersma Everardus
Otto Maria Orlemans
Original Assignee
Akzo Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nv filed Critical Akzo Nv
Publication of MX9207394A publication Critical patent/MX9207394A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/36—Antigestagens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0077—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 substituted in position 11-beta by a carbon atom, further substituted by a group comprising at least one further carbon atom
    • C07J41/0083—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 substituted in position 11-beta by a carbon atom, further substituted by a group comprising at least one further carbon atom substituted in position 11-beta by an optionally substituted phenyl group not further condensed with other rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Saccharide Compounds (AREA)

Abstract

La invención se refiere a novedosos esteroides de 17-espirofuran-3'-ilideno, a métodos para su preparación, a composiciones farmacéuticas que los contienen, y al empleo de estos esteroides para la fabricación de un medicamento que tiene actividad antiprogestina.
MX9207394A 1991-12-20 1992-12-17 Esteroides de 17-espirofuran-3'-ilideno. MX9207394A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP91203366 1991-12-20

Publications (1)

Publication Number Publication Date
MX9207394A true MX9207394A (es) 1993-07-30

Family

ID=8208088

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9207394A MX9207394A (es) 1991-12-20 1992-12-17 Esteroides de 17-espirofuran-3'-ilideno.

Country Status (17)

Country Link
US (1) US5292878A (es)
EP (1) EP0549041B1 (es)
JP (1) JP3462515B2 (es)
KR (1) KR100287513B1 (es)
AT (1) ATE128983T1 (es)
AU (1) AU655858B2 (es)
CA (1) CA2084431C (es)
DE (1) DE69205405T2 (es)
DK (1) DK0549041T3 (es)
ES (1) ES2081040T3 (es)
FI (1) FI104178B1 (es)
GR (1) GR3018630T3 (es)
HK (1) HK1002033A1 (es)
MX (1) MX9207394A (es)
NO (1) NO302525B1 (es)
NZ (1) NZ245520A (es)
ZA (1) ZA929315B (es)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2100514C (en) * 1992-07-29 2005-03-29 Johannes A. M. Hamersma 17-spiromethylene steroids
CN1281363A (zh) * 1997-11-14 2001-01-24 阿克佐诺贝尔公司 孕激素-抗孕激素体系
US6020328A (en) * 1998-03-06 2000-02-01 Research Triangle Institute 20-keto-11β-arylsteroids and their derivatives having agonist or antagonist hormonal properties
WO1999061055A1 (en) 1998-05-22 1999-12-02 The Board Of Trustees Of The Leland Stanford Junior University Bifunctional molecules and therapies based thereon
US6262042B1 (en) 1998-05-29 2001-07-17 Research Triangle Institute 17β-amino and hydroxylamino-11β-arylsteroids and their derivatives having agonist or antagonist hormonal properties
US5962444A (en) * 1998-05-29 1999-10-05 Research Triangle Institute 17β-nitro-11β-arylsteroids and their derivatives having agonist or antagonist hormonal properties
SK15502001A3 (sk) * 1999-04-29 2002-03-05 Akzo Nobel N. V. Použitie Org 33245
US6043235A (en) * 1999-07-21 2000-03-28 Research Triangle Institute 11β-aryl-17, 17-spirothiolane-substituted steroids
US7426602B2 (en) * 2004-01-08 2008-09-16 Topside Research, Llc Switch for bus optimization
TW200531977A (en) 2004-03-25 2005-10-01 Akzo Nobel Nv Progesterone receptor modulators
CA2789097C (en) 2005-04-28 2017-02-21 Proteus Digital Health, Inc. Pharma-informatics system
WO2007035716A2 (en) 2005-09-16 2007-03-29 Raptor Pharmaceutical Inc. Compositions comprising receptor-associated protein (rap) variants specific for cr-containing proteins and uses thereof
AU2007217095B2 (en) * 2006-02-17 2012-05-03 Janssen Pharmaceutica N.V. 17-phosphorous steroid derivatives useful as progesterone receptor modulators
WO2007098381A2 (en) * 2006-02-17 2007-08-30 Janssen Pharmaceutica N.V. 11-phosphorous steroid derivatives useful as progesterone receptor modulators
HUE036870T2 (hu) 2006-10-24 2018-08-28 Repros Therapeutics Inc Az endometriális proliferáció elnyomására szolgáló készítmények és módszerek
TWI539953B (zh) 2008-04-28 2016-07-01 瑞波若斯治療學公司 用於治療乳癌之組成物和方法
NZ616673A (en) 2009-02-20 2014-08-29 To Bbb Holding B V Glutathione-based drug delivery system
US8673968B2 (en) * 2009-04-06 2014-03-18 Evestra, Inc. Progesterone antagonists
ES2942923T3 (es) 2009-05-06 2023-06-07 Laboratory Skin Care Inc Composiciones de administración dérmica que comprenden complejos de agente activo-partículas de fosfato de calcio y métodos de uso de las mismas
CN101926806A (zh) * 2009-06-24 2010-12-29 天津金耀集团有限公司 一种17磷类雌甾化合物在制备紧急避孕药物中的应用
US20130018027A1 (en) 2010-03-22 2013-01-17 Repros Therapeutics Inc. Compositions and methods for non-toxic delivery of antiprogestins
US20130272956A1 (en) * 2010-06-17 2013-10-17 Franciscus Theodorus Leonardus Brands (11beta, 17alpha)-11-(4-(2-11C-ACETYL)PHENYL)-17,23-EPOXY-19,24-DINORCHOLA-4,9,20-TRIEN-3-ONE
US9096641B2 (en) 2013-06-05 2015-08-04 Evestra, Inc. Imidazolyl progesterone antagonists

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3461090D1 (en) * 1983-02-18 1986-12-04 Schering Ag 11-beta-aryl-estradienes, process for their preparation and pharmaceutical compositions containing them
FR2596395B1 (fr) * 1986-03-26 1989-05-26 Roussel Uclaf Nouveaux steroides comportant un cycle spirannique en position 17, leur procede de preparation, leur application comme medicaments et les compositions les renfermant
EP0254341B1 (en) * 1986-07-23 1990-01-03 Akzo N.V. Novel 18-phenyloestrane derivatives
IE60780B1 (en) * 1987-01-23 1994-08-10 Akzo Nv New 11-aryl steroid derivatives
EP0289073B1 (en) * 1987-04-24 1991-11-27 Akzo N.V. Novel 11-aryloestrane and 11-arylpregnane derivatives
ES2053714T3 (es) * 1987-12-12 1994-08-01 Akzo Nv Proceso para la preparacion de 11-arilesteroides.

Also Published As

Publication number Publication date
NZ245520A (en) 1995-02-24
FI925790L (fi) 1993-06-21
NO924857D0 (no) 1992-12-15
HK1002033A1 (en) 1998-07-24
NO302525B1 (no) 1998-03-16
EP0549041B1 (en) 1995-10-11
ZA929315B (en) 1993-05-24
CA2084431C (en) 2003-04-08
DE69205405D1 (de) 1995-11-16
NO924857L (no) 1993-06-21
AU3009392A (en) 1993-06-24
ATE128983T1 (de) 1995-10-15
EP0549041A1 (en) 1993-06-30
FI104178B (fi) 1999-11-30
JPH05255380A (ja) 1993-10-05
DK0549041T3 (da) 1996-01-29
JP3462515B2 (ja) 2003-11-05
DE69205405T2 (de) 1996-05-09
US5292878A (en) 1994-03-08
FI925790A0 (fi) 1992-12-18
FI104178B1 (fi) 1999-11-30
KR100287513B1 (ko) 2001-05-02
AU655858B2 (en) 1995-01-12
GR3018630T3 (en) 1996-04-30
CA2084431A1 (en) 1993-06-21
ES2081040T3 (es) 1996-02-16

Similar Documents

Publication Publication Date Title
MX9207394A (es) Esteroides de 17-espirofuran-3'-ilideno.
MX9304581A (es) Desoxitaxoles y composiciones farmaceuticas que los contienen
MX9100990A (es) Compuesto monohidrato de furoato de mometasona,al procedimiento para su preparacion y a las composiciones farmaceuticas
IT8619625A0 (it) Composizioni farmaceutiche per inalazione.
ES2079719T3 (es) Derivados de amidinofenilalanina, procedimiento para su preparacion, su utilizacion y agentes que los contienen en calidad de anticoagulantes.
ATE74003T1 (de) Waessriges pharmazeutisches praeparat.
ATE22562T1 (de) 6-substituierte s-triazolo(3,4-a)phthalazinderivate.
ES2126766T3 (es) 7-azaindol-3-ilcarboxiamidas de tropilo como agente antitusivo.
MX9204844A (es) Derivados de benzodioxano, procedimiento para su preparacion composiciones farmaceuticas que los contienen.
IL107870A0 (en) Pharmaceutical compositions having antidepressant activity comprising pramipexol
GR850472B (es)
MX9304793A (es) Glicanas de actividad inmunoestimulante.
EP0169392A3 (en) Triazolobenzodiazepines and pharmaceutical compositions containing them
MX9300779A (es) 3-(1h-tetrazol-5-y1)-4h-pyrido[1,2-a]pirimidina-4-onas composiciones farmaceuticas que las contienen y su preparacion de las mismas
DK0400522T3 (da) Fremgangsmåde til fremstilling af mikroniserede bionedbrydelige partikler
MX9303123A (es) Ciclopentano-y-penteno-beta-aminoacidos, procedimiento para su preparacion y medicamentos que los contienen.
MX9202935A (es) Derivados de 2,3-dihidro-1h-indeno y composicion farmaceutica que los contiene.
ES2145234T3 (es) Derivados de la diosmetina, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
MX9307203A (es) COMPUESTOS ESTEROIDALES DE ACIL-3-CARBOXI-3,5-DIENO-17Ó Y 17ß -SUBSTITUIDOS.
MX9303970A (es) COMPUESTOS ESTEROIDALES DE ANILLO A DE 17Ó Y 17ß-ALQUILCETONA-3-CARBOXIAROMATICO.
MX9203383A (es) Nuevos derivados de piridobenzoindol y composiciones farmaceuticas que los contienen.
GR1002576B (el) Φαρμακευτικες συνθεσεις και μια μεθοδος παρασκευης τους.
MX9203732A (es) R-enentiomeros de compuestos de n-propargil-1-aminoindan, su preparacion y composiciones farmaceuticas que contienen los mismos.
RU95109891A (ru) 19,11-перекрытые мостиками 4-эстрены, способ их получения, содержащая их фармацевтическая композиция и промежуточные соединения для их получения
PT1001942E (pt) Poli-hidroxibutilpirazinas sua preparacao e medicamentos que as contem

Legal Events

Date Code Title Description
FG Grant or registration
GB Transfer or rights
HC Change of company name or juridical status

Owner name: SKW POLYMERS GMBH

PD Change of proprietorship

Owner name: N.V. ORGANON.*

MM Annulment or lapse due to non-payment of fees